InflaRx (IFRX) EBT Margin (QoQ) (2018 - 2026)
InflaRx (IFRX) EBT Margin (QoQ) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.64 Bn | 130.78 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.89 Bn | 77.90 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.11 Bn | 59.93 Bn | 1.37 Bn |
| 4 | Moderna | 55.83 Bn | 50.69 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.01 Bn | 36.91 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.63 Bn | 28.32 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.65 Bn | 9.26 Bn | 668.28 Mn |
| 8 | Insmed | 27.46 Bn | 26.30 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.30 Bn | 26.47 Bn | - |
| 10 | InflaRx | 138.28 Mn | -45.97 Mn | 2.74 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 35,431.00 |
| Dec 31, 2025 | 3.79 Mn |
| Sep 30, 2025 | -642,606.00 |
| Jun 30, 2025 | 326,219.00 |
| Mar 31, 2025 | -3.48 Mn |
| Dec 31, 2024 | 1.19 Mn |
| Sep 30, 2024 | 21.72 Mn |
| Jun 30, 2024 | -19.69 Mn |
| Mar 31, 2024 | -3.21 Mn |
| Dec 31, 2023 | -2,734.00 |
| Sep 30, 2023 | -52,804.00 |
| Jun 30, 2023 | 52,825.00 |
| Mar 31, 2023 | 416,454.00 |
| Dec 31, 2022 | -470,622.00 |
| Sep 30, 2022 | 50,865.00 |
| Jun 30, 2022 | -149,227.00 |
| Mar 31, 2022 | -60.73 Mn |
| Dec 31, 2021 | 60.74 Mn |
| Sep 30, 2021 | 154,061.00 |
| Jun 30, 2021 | -26,186.00 |